75 related articles for article (PubMed ID: 17206708)
1. Remission-inducing effect of anti-TNF monoclonal antibody in TNBS colitis: mechanisms beyond neutralization?
Shen C; de Hertogh G; Bullens DM; Van Assche G; Geboes K; Rutgeerts P; Ceuppens JL
Inflamm Bowel Dis; 2007 Mar; 13(3):308-16. PubMed ID: 17206708
[TBL] [Abstract][Full Text] [Related]
2. Targeting Inflammation and Oxidative Stress to Improve Outcomes in a TNBS Murine Crohn's Colitis Model.
Apte A; Bardill JR; Canchis J; Skopp SM; Fauser T; Lyttle B; Vaughn AE; Seal S; Jackson DM; Liechty KW; Zgheib C
Nanomaterials (Basel); 2024 May; 14(10):. PubMed ID: 38786849
[TBL] [Abstract][Full Text] [Related]
3. Correlation between neuregulin receptor degradation protein-1 and Crohn's disease.
Zong CY; Ji QQ; Chen FF; Yang JJ; Zhou H; Zhu BF; Zhou GX
J Physiol Pharmacol; 2024 Feb; 75(1):. PubMed ID: 38583443
[TBL] [Abstract][Full Text] [Related]
4. Effect of vitamin D
Gezer A; Aras SY; Baygutalp NK; Sari EK; Bedir G; Mokhtare B; Yilmaz K
Vet Med (Praha); 2024 Mar; 69(3):84-93. PubMed ID: 38623153
[TBL] [Abstract][Full Text] [Related]
5. Interleukin-18 Inhibition in Inflammatory Bowel Disease: A Delicate Balance.
Geertsema S; Fagundes RR; Otten AT; Dijkstra G; Faber KN; Bourgonje AR
Inflamm Bowel Dis; 2024 Apr; 30(4):693-694. PubMed ID: 38442894
[No Abstract] [Full Text] [Related]
6. Reply: Interleukin-18 Inhibition in Inflammatory Bowel Diseases: A Delicate Balance.
Maeda K; Kawashima H
Inflamm Bowel Dis; 2024 Apr; 30(4):695-696. PubMed ID: 38442897
[No Abstract] [Full Text] [Related]
7. Expression of Concern: Glutamine Treatment Attenuates Endoplasmic Reticulum Stress and Apoptosis in TNBS-Induced Colitis.
PLOS ONE Editors
PLoS One; 2024; 19(1):e0297611. PubMed ID: 38241231
[No Abstract] [Full Text] [Related]
8. Neutralization of membrane TNF, but not soluble TNF, is crucial for the treatment of experimental colitis.
Perrier C; de Hertogh G; Cremer J; Vermeire S; Rutgeerts P; Van Assche G; Szymkowski DE; Ceuppens JL
Inflamm Bowel Dis; 2013 Feb; 19(2):246-53. PubMed ID: 22649027
[TBL] [Abstract][Full Text] [Related]
9. Chemically induced mouse models of acute and chronic intestinal inflammation.
Wirtz S; Popp V; Kindermann M; Gerlach K; Weigmann B; Fichtner-Feigl S; Neurath MF
Nat Protoc; 2017 Jul; 12(7):1295-1309. PubMed ID: 28569761
[TBL] [Abstract][Full Text] [Related]
10. Novel bispecific nanobody mitigates experimental intestinal inflammation in mice by targeting TNF-α and IL-23p19 bioactivities.
Wang J; Kang G; Lu H; de Marco A; Yuan H; Feng Z; Gao M; Wang X; Wang H; Zhang X; Wang Y; Zhang M; Wang P; Feng Y; Liu Z; Cao X; Huang H
Clin Transl Med; 2024 Mar; 14(3):e1636. PubMed ID: 38533646
[TBL] [Abstract][Full Text] [Related]
11. Catechol-O-Methyltransferase Loss Drives Cell-Specific Nociceptive Signaling via the Enteric Catechol-O-Methyltransferase/microRNA-155/Tumor Necrosis Factor α Axis.
Zhou Q; Yang L; Verne ML; Zhang BB; Fields J; Verne GN
Gastroenterology; 2023 Apr; 164(4):630-641.e34. PubMed ID: 36623778
[TBL] [Abstract][Full Text] [Related]
12. The effect of montelukast, a leukotriene receptor antagonist, on the acetic acid-induced model of colitis in rats: Involvement of NO-cGMP-K
Ghorbanzadeh B; Behmanesh MA; Mahmoudinejad R; Zamaniyan M; Ekhtiar S; Paridar Y
Front Pharmacol; 2022; 13():1011141. PubMed ID: 36225573
[TBL] [Abstract][Full Text] [Related]
13. Activation pathways that drive CD4
Krovi SH; Kuchroo VK
Immunol Rev; 2022 May; 307(1):161-190. PubMed ID: 35142369
[TBL] [Abstract][Full Text] [Related]
14. Self-tunable engineered yeast probiotics for the treatment of inflammatory bowel disease.
Scott BM; Gutiérrez-Vázquez C; Sanmarco LM; da Silva Pereira JA; Li Z; Plasencia A; Hewson P; Cox LM; O'Brien M; Chen SK; Moraes-Vieira PM; Chang BSW; Peisajovich SG; Quintana FJ
Nat Med; 2021 Jul; 27(7):1212-1222. PubMed ID: 34183837
[TBL] [Abstract][Full Text] [Related]
15. Effects of anti-TNF-α in experimental diversion colitis.
Buanaim RP; Pereira JA; Campos FG; Kotze PG; Goto EFK; Mendonça RLS; Kanno DT; Martinez CAR
Acta Cir Bras; 2019; 34(10):e201901004. PubMed ID: 31851212
[TBL] [Abstract][Full Text] [Related]
16. Transcribed ultraconserved region (T-UCR) uc.261 expression is closely correlated with disease activity and intestinal permeability in Crohn's disease.
Qian XX; Cai CW; Li HY; Lai LJ; Song DJ; Qiao YQ; Shen J; Ran ZH
Therap Adv Gastroenterol; 2019; 12():1756284819880733. PubMed ID: 31662792
[TBL] [Abstract][Full Text] [Related]
17. Antioxidant and Anti-Inflammatory Properties of a
Stan MS; Voicu SN; Caruntu S; Nica IC; Olah NK; Burtescu R; Balta C; Rosu M; Herman H; Hermenean A; Dinischiotu A
Antioxidants (Basel); 2019 Sep; 8(9):. PubMed ID: 31546840
[TBL] [Abstract][Full Text] [Related]
18. Mucosal delivery of Lactococcus lactis carrying an anti-TNF scFv expression vector ameliorates experimental colitis in mice.
Chiabai MJ; Almeida JF; de Azevedo MGD; Fernandes SS; Pereira VB; de Castro RJA; Jerônimo MS; Sousa IG; de Souza Vianna LM; Miyoshi A; Bocca AL; Maranhão AQ; Brigido MM
BMC Biotechnol; 2019 Jun; 19(1):38. PubMed ID: 31238939
[TBL] [Abstract][Full Text] [Related]
19. Effector T Helper Cell Subsets in Inflammatory Bowel Diseases.
Imam T; Park S; Kaplan MH; Olson MR
Front Immunol; 2018; 9():1212. PubMed ID: 29910812
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
